Sandoz Group AG (VIE:SDZ)

Austria flag Austria · Delayed Price · Currency is EUR
60.98
-0.24 (-0.39%)
At close: Dec 4, 2025
Market Cap 26.53B
Revenue (ttm) 9.01B
Net Income (ttm) 193.29M
Shares Out n/a
EPS (ttm) 0.45
PE Ratio 137.25
Forward PE 19.63
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 133
Open 61.48
Previous Close 61.22
Day's Range 60.98 - 61.48
52-Week Range 52.52 - 62.06
Beta n/a
RSI 73.46
Earnings Date Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 22,049
Stock Exchange Vienna Stock Exchange
Ticker Symbol SDZ
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.